MDRX News and Press, Allscripts Healthcare Solutions Inc. From 12/13/23

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 investing in Veradigm securities between February 26, 2021 and June 13, 2023 and ...

2023-12-13 16:18:50 ET More on Veradigm Veradigm: Some Promise Combined With Uncertainty Veradigm reshuffles top management over audit committee probe Historical earnings data for Veradigm For further details see: Veradigm announces that Nasdaq hearings p...

Veradigm Inc. (NASDAQ: MDRX (the “Company”)) announced today that it received a decision from the Nasdaq Hearings Panel (the “Panel”) granting its request for continued listing on the Nasdaq Capital Market, subject to the Company demonstrating compliance with Nasdaq Li...

SAN DIEGO, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in Veradigm Inc. (NASDAQ: MDRX) shares. Investors, who purchased shares of Veradigm Inc. (NASDAQ: MDRX) prior to February 2021 and continue to hold any of ...

Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions, announced today that it will now offer a conversational artificial intelligence (AI) agent for Practice Fusion Billing Services, a Veradigm Network solution. Created to quickly answer questions in a co...

NEW YORK, Dec. 08, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP reminds shareholders that a complaint has been filed on behalf of purchasers of the common stock of Veradigm Inc (“Veradigm” or the “Company”) (NASDAQ: MDRX), a healthcare technology company, b...

2023-12-08 12:45:17 ET Gainers: Intensity Therapeutics ( INTS ) +100% . MBIA ( MBI ) +74% . Conduit Pharmaceuticals ( CDT ) +47% . EF Hutton Acquisition Corp I ( EFHT ) +44% . Alx Oncology Holdings ( ALXO ) +35% . View ( VI...

2023-12-08 09:00:53 ET More on Veradigm Veradigm: Some Promise Combined With Uncertainty Veradigm announces receipt of Nasdaq delisting notice Veradigm provides audit update and updates financial guidance for 2023 For further details see: Veradigm reshuff...

lululemon athletica inc. (LULU) is expected to report $2.27 for Q3 2024 Arco Platform Limited (ARCE) is expected to report $-0.17 for Q3 2023 Elekta AB ADR (EKTAY) is expected to report for Q2 2024 Kimberly - Clark de Mexico S.A. ADR (KCDMY) is expected to report for Q1 2024 Torri...

SAN FRANCISCO, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Veradigm Inc. (NASDAQ: MDRX) investors who suffered substantial losses to submit your losses now . Class Period: Feb. 26, 2021 – June 13, 2023 Lead Plaintiff Deadline: Jan. 22, 2024 Visit: ...